Scarica l'app Stockscreener
12.02
13.18%
1.40
Pre-mercato:
11.98
-0.04
-0.33%
Precedente Chiudi:
$10.62
Aprire:
$11.1694
Volume 24 ore:
13.71M
Relative Volume:
2.45
Capitalizzazione di mercato:
$1.58B
Reddito:
$2.59B
Utile/perdita netta:
$-981.73M
Rapporto P/E:
-0.4874
EPS:
-24.66
Flusso di cassa netto:
$206.95M
1 W Prestazione:
+32.82%
1M Prestazione:
+40.26%
6M Prestazione:
+4.70%
1 anno Prestazione:
-30.72%
Intervallo 1D:
$11.10
$12.39
Intervallo di 1 settimana:
$8.70
$12.39
Portata 52W:
$6.76
$22.54
Teladoc Health Inc Stock (TDOC) Company Profile
Nome
Teladoc Health Inc
Settore
Industria
Telefono
(203) 635-2002
Indirizzo
2 MANHATTANVILLE ROAD, PURCHASE, NY
Confronta TDOC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
12.02 | 1.58B | 2.59B | -981.73M | 206.95M | -24.66 |
|
VEEV
Veeva Systems Inc
|
226.95 | 36.75B | 2.57B | 615.26M | 996.76M | 3.32 |
|
SOLV
Solventum Corp
|
71.61 | 12.37B | 8.26B | 66.00M | 1.17B | 0.00 |
|
TEM
Tempus Ai Inc
|
63.89 | 10.06B | 640.44M | -743.28M | -206.93M | 0.00 |
|
DOCS
Doximity Inc
|
48.75 | 9.00B | 493.63M | 160.55M | 162.20M | 0.55 |
|
HQY
Healthequity Inc
|
103.76 | 8.83B | 1.10B | 105.67M | -197.98M | 0.1475 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-15 | Iniziato | Goldman | Buy |
| 2024-09-17 | Reiterato | Jefferies | Hold |
| 2024-02-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-17 | Downgrade | DA Davidson | Buy → Neutral |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-04-12 | Iniziato | Stephens | Equal-Weight |
| 2023-02-23 | Aggiornamento | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Aggiornamento | Guggenheim | Sell → Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-17 | Downgrade | Guggenheim | Neutral → Sell |
| 2022-08-12 | Iniziato | DA Davidson | Buy |
| 2022-08-02 | Downgrade | Berenberg | Buy → Hold |
| 2022-08-02 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-07-28 | Downgrade | Goldman | Buy → Neutral |
| 2022-07-28 | Downgrade | Needham | Buy → Hold |
| 2022-07-06 | Reiterato | BofA Securities | Neutral |
| 2022-05-05 | Downgrade | Argus | Buy → Hold |
| 2022-04-28 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-28 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2022-04-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-03 | Aggiornamento | Argus | Hold → Buy |
| 2022-02-23 | Reiterato | BofA Securities | Neutral |
| 2022-02-23 | Reiterato | Craig Hallum | Hold |
| 2022-02-23 | Reiterato | Evercore ISI | In-line |
| 2022-02-23 | Reiterato | Goldman | Buy |
| 2022-02-23 | Reiterato | JP Morgan | Overweight |
| 2022-02-23 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Reiterato | Needham | Buy |
| 2022-02-23 | Reiterato | Oppenheimer | Outperform |
| 2022-02-23 | Reiterato | Stifel | Hold |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2022-02-08 | Reiterato | Piper Sandler | Overweight |
| 2021-12-02 | Ripresa | Jefferies | Hold |
| 2021-11-22 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-10-28 | Reiterato | Barclays | Equal Weight |
| 2021-10-28 | Reiterato | BofA Securities | Neutral |
| 2021-10-28 | Reiterato | Canaccord Genuity | Buy |
| 2021-10-28 | Reiterato | Citigroup | Buy |
| 2021-10-28 | Reiterato | Craig Hallum | Hold |
| 2021-10-28 | Reiterato | Needham | Buy |
| 2021-10-28 | Reiterato | Oppenheimer | Outperform |
| 2021-10-28 | Reiterato | Piper Sandler | Overweight |
| 2021-10-28 | Reiterato | UBS | Neutral |
| 2021-10-19 | Iniziato | Wells Fargo | Overweight |
| 2021-08-02 | Downgrade | Argus | Buy → Hold |
| 2021-07-28 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Iniziato | Robert W. Baird | Neutral |
| 2021-04-15 | Iniziato | Needham | Buy |
| 2021-01-07 | Iniziato | BTIG Research | Buy |
| 2020-12-22 | Iniziato | Evercore ISI | In-line |
| 2020-12-07 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Iniziato | Goldman | Neutral |
| 2020-11-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Iniziato | DA Davidson | Buy |
| 2020-09-02 | Aggiornamento | Berenberg | Hold → Buy |
| 2020-08-17 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Iniziato | Citigroup | Buy |
| 2020-07-13 | Iniziato | Argus | Buy |
| 2020-07-07 | Iniziato | Stephens | Overweight |
| 2020-04-30 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Iniziato | SVB Leerink | Outperform |
| 2020-03-31 | Downgrade | Berenberg | Buy → Hold |
| 2020-03-25 | Downgrade | Craig Hallum | Buy → Hold |
| 2020-03-16 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Iniziato | UBS | Neutral |
| 2020-01-09 | Downgrade | BofA/Merrill | Buy → Neutral |
Mostra tutto
Teladoc Health Inc Borsa (TDOC) Ultime notizie
Teladoc Health Expands AI Virtual Sitter Solution To Enhance Patient Care And Safety, Shares Rise - Nasdaq
Teladoc Health launches AI-driven Virtual Sitter solution - Investing.com India
Teladoc Health launches AI-driven Virtual Sitter solution By Investing.com - Investing.com UK
Teladoc Health Expands AI Capabilities for Hospitals and Health Systems with Advanced Virtual Sitter Solution - GlobeNewswire
Teladoc Health Unveils AI-Enhanced Patient Monitoring, Boosts Staff Efficiency by 25% | TDOC Stock News - StockTitan
Robust Growth in Remote Health Evaluation Tools Market - openPR
Future-Proofing Growth of E-Health Consultation Services - openPR
168,166 Shares in Teladoc Health, Inc. (NYSE:TDOC) Purchased by Jennison Associates LLC - MarketBeat
Teladoc (TDOC) Harnesses AI for Diabetes Care, Stock Rises 6.7% - MSN
Teladoc Health Inc (TDOC)Friday, Aug 23, 2024 - Smartkarma
Future-Proofing Growth Connected Health Therapies Market, - openPR
Teladoc Health To Participate In Upcoming Investor Conference - Barchart
Teladoc Health to Participate in Upcoming Investor Conference - GlobeNewswire
Teladoc Health Leadership to Present at Piper Sandler Healthcare Conference | TDOC Stock News - StockTitan
Top 5 Indicators Shaping the Future of Telemedicine in Healthcare: Key Companies, Market Growth and Insights - Spherical Insights
Teladoc Health, Inc. (NYSE:TDOC) Shares Bought by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Telehealth Services Market Future Business Opportunities - openPR
Virtual Health Service Market Future Business Opportunities - openPR
Teladoc’s long-time CEO is out, and the stock bounces off an 8-year low - MSN
Teladoc started at buy at Goldman Sachs on membership, revenue growth - MSN
2 Former Pandemic Darlings Eyeing a Big 2025 Turnaround - MarketBeat
U.S. Telemedicine Market Size, Trends, Growth, Opportunities (2024-2032) | American Well and Teladoc Health Inc. - openPR
If You'd Invested $10,000 in Teladoc Stock 5 Years Ago, Here's How Much You'd Have Today - AOL
Telemental Health Market: Growth, Opportunities, and Challenges - openPR
Zacks Research Weighs in on Teladoc Health FY2024 Earnings - MarketBeat
Teladoc Health Inc (TDOC-N) QuotePress Release - The Globe and Mail
Where Will Teladoc Be In 5 Years? - Barchart
Where Will Teladoc Be in 5 Years? - Yahoo Finance
TDOC (Teladoc Health) Cash From Other Investing Activities : $0 Mil (TTM As of Sep. 2024) - GuruFocus.com
Goldman Sachs Initiates Coverage of Teladoc Health (TDOC) with Buy Recommendation - MSN
Teladoc Health (NYSE:TDOC) Shares Gap UpShould You Buy? - MarketBeat
Teladoc Health (NYSE:TDOC) Now Covered by The Goldman Sachs Group - MarketBeat
Goldman Sachs sets Teladoc target at $14 with Buy rating - Investing.com
Teladoc's SWOT analysis: virtual care leader's stock faces growth hurdles - Investing.com
Is Teladoc Health Stock A Buy? - Barchart
Entropy Technologies LP Reduces Stock Position in Teladoc Health, Inc. (NYSE:TDOC) - MarketBeat
Is Teladoc Health Stock a Buy? - AOL
Virtual Care Market to Achieve a Superb CAGR from 2024 To 2031 - openPR
Teladoc Health, Inc. (NYSE:TDOC) Receives Average Rating of "Hold" from Analysts - MarketBeat
Future-Proofing Growth of Telemedicine Appointment Tools - openPR
Hims & Hers, Talkspace among Q3 winners in digital health - Modern Healthcare
Distance Health Technology Market: Future Scope, Growth - openPR
Telehealth Solutions Market Outlook: Competitor Insights - openPR
(TDOC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Robeco Institutional Asset Management B.V. Boosts Stock Holdings in Teladoc Health, Inc. (NYSE:TDOC) - MarketBeat
Telehealth company Boulder Care raises profile with prominent executive hires - Fierce healthcare
Teladoc Health Announces Employee Inducement Awards Under NYSE Rule 303A.08 - StockTitan
Online Doctor Consultation Market to Grow by USD 38.87 Billion from 2024-2028, Driven by Rising Infectious Diseases and AI-Driven Market TransformationTechnavio - The Malaysian Reserve
ISRG: 3 Healthcare Stocks Innovating with AI - StockNews.com
Teladoc Health Q3 Loss Narrows on Strong Integrated Care Unit - MSN
Every Teladoc Investor Should Keep an Eye on This Number - Yahoo Finance
Teladoc Health Inc Azioni (TDOC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.22%
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):